MP57-06 MANAGEMENT OF ENZALUTAMIDE-RELATED ADVERSE EVENTS FOR CRPC PATIENTS BY USING PATIENT REPORTED OUTCOMES LEADS BETTER PROGNOSIS

Autor:	Yuji Takeyama, Minoru Kato, Sayaka Yasuda, Taro Iguchi, Tatsuya Nakatani, Yasuomi Shimizu, Satoshi Tamada, Takeshi Yamasaki
Rok vydání:	2017
Předmět:	Oncology chemistry.chemical_compound medicine.medical_specialty chemistry business.industry Urology Internal medicine medicine Enzalutamide Adverse effect business
Zdroj:	Journal of Urology. 197
ISSN:	1527-3792 0022-5347
DOI:	10.1016/j.juro.2017.02.1780
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9e6a5a608ade242c16e3b109c0bd7bfe https://doi.org/10.1016/j.juro.2017.02.1780 Zobrazit plný text záznamu